StonvexLoading…
StonvexStonvexStonvexCore line items from CMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $342.35M | $332.93M | $309.39M | $279.07M |
Operating Income | $-16.22M | $-41.68M | $-72.44M | $-140.57M |
Net Income | $-19.34M | $-27.03M | $-64.67M | $-139.92M |
EPS (Diluted) | $-0.24 | $-0.35 | $-0.86 | $-1.91 |
Total Assets | $308.79M | $340.29M | $444.06M | $474.06M |
Total Liabilities | $269.44M | $306.92M | $418.52M | $428.38M |
Cash & Equivalents | $44.26M | $88.88M | $71.72M | $91.57M |
Free Cash Flow OCF − CapEx | $16.89M | $22.53M | $-28.42M | $-94.55M |
Shares Outstanding | 81.65M | 78.57M | 76.41M | 73.94M |